Sun Pharma board approves plan to raise up to ₹10,000 crore via NCDs
The decision was taken at a meeting of the company's Board of Directors held on October 12, Sun Pharma said in a regulatory filing
We haven't written up this one. Business Standard IN has the full story — the link below goes straight to it.